The Challenge
- Introduction of new treatments is complicated, and takes a long time.
- Traditional forms of healthcare lobbying are not efficient enough.
- Patients could be even stronger advocates for better healthcare, but their organisations are not united.
- Novartis needed to show dedication to their commitment to patients and build trust with the patient community.
Better possibilities for everyone to be co-creators in their own healthcare is crucial to tackle the increased prevalence of chronic diseases, and inequalities in health.
Research shows the clear benefits, both in terms of results and costs, of putting the patient's unique life situation at the...